CNTB Stock Price History and Quote Analysis Insights for Investors
Connect Biopharma Holdings Limited
Stock Price Today
Connect Biopharma Holdings Limited (CNTB) stock declined over -0.14%, trading at $1.12 on NASDAQ, down from the previous close of $1.12. The stock opened at $1.23, fluctuating between $1.10 and $1.23 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.
Company Information
| Employees | 81 |
| Beta | -0.31 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Connect Biopharma Holdings Limited (NASDAQ: CNTB) stock price is $1.12 in the last trading session. During the trading session, CNTB stock reached the peak price of $1.23 while $1.10 was the lowest point it dropped to. The percentage change in CNTB stock occurred in the recent session was -0.14% while the dollar amount for the price change in CNTB stock was -$0.00.
The NASDAQ listed CNTB is part of Biotechnology industry that operates in the broader Healthcare sector. Connect Biopharma Holdings Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Steven Chan
Chief Financial Officer
Dr. Chin Lee M.D., M.P.H.
Chief Medical Officer
Mr. Jiang Bian J.D.
Gen. Counsel & Chief Compliance Officer
Dr. Wubin Pan M.B.A., Ph.D.
Co-Founder, Pres & Chairman of Directors
Dr. Raul Collazo Ph.D.
Vice President & Global Head of Medical Affairs
Dr. Lei Sun Ph.D.
Vice President of Biologics & Head of CMC
Dr. Malinda V. Longphre Ph.D.
Vice President & Head of US Clinical Operations
Dr. Zheng Wei Ph.D.
Co-Founder, Chief Executive Officer & Director
CNTB's closing price is 45.25% higher than its 52-week low of $0.77 where as its distance from 52-week high of $2.66 is -57.95%.
Number of CNTB employees currently stands at 81.
Official Website of CNTB is: https://www.connectbiopharm.com
CNTB could be contacted at phone 865 125 3577866 and can also be accessed through its website. CNTB operates from East R&D Building, Taicang, 215400, China.
CNTB stock volume for the day was 11.84K shares. The average number of CNTB shares traded daily for last 3 months was 27.64K.
The market value of CNTB currently stands at $61.80M with its latest stock price at $1.12 and 55.25M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com